GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
Hong Kong is Asia’s largest and the world’s second-largest destination for biotech companies wanting to go public. Amidst the backdrop of COVID-19 and changes in the political and regulatory environment in 2021, companies have forged on to make a splash on the HKEX. Here are 10 of them, ranked by the size of their IPOs.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02